Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines

Journal of Virology

Volumn 80, Issue 22, 2006, Pages 11409-11415

  Gattelli, Albana ^a,b   Zimberlin, María N ^a,b   Meiss, Roberto P ^b   Castilla, Lucio H ^c   Kordon, Edith C ^a,b  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE INSERTION; GENE MUTATION; GENE OVEREXPRESSION; INT7 GENE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RSPO3 GENE; TUMOR CELL LINE; TUMOR GROWTH; VIRUS GENE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MUTATION; RECOMBINATION, GENETIC; RETROVIRIDAE INFECTIONS; SELECTION (GENETICS); TUMOR VIRUS INFECTIONS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 33750713384     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00234-06     Document Type: Article

References (25)

1. Benson, D. A., I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, and D. L. Wheeler. 2004. GenBank: update. Nucleic Acids Res. 32:D23-D26.
2. Besta, F., S. Massberg, K. Brand, E. Muller, S. Page, S. Gruner, M. Lorenz, K. Sadoul, W. Kolanus, E. Lengyel, and M. Gawaz. 2002. Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor. J. Cell Sci. 115:3879-3888.
3. Buggiano, V., C. S. Levy, A. Gattelll, M. C. Cirio, M. Marfil, I. Nepomnaschy, I. Piazzon, L. Helguero, S. Vanzulli, and E. C. Kordon. 2002. Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Breast Cancer Res. Treat. 75:191-202.
4. Buggiano, V., C. Schere-Levy, K. Abe, S. Vanzulli, I. Piazzon, G. H. Smith, and E. C. Kordon. 2001. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. Int. J. Cancer 92:568-576.
5. Castilla, L. H., P. Perrat, N. J. Martinez, S. F. Landrette, R. Keys, S. Oikemus, J. Flanegan, S. Heilman, L. Garrett, A. Dutra, S. Anderson, G. A. Pihan, L. Wolff, and P. P. Liu. 2004. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 101:4924-4929.
6. Chen, J. Z., S. Wang, R. Tang, Q. S. Yang, E. Zhao, Y. Chao, K. Ying, Y. Xie, and Y. M. Mao. 2002. Cloning and identification of a cDNA that encodes a novel human protein with thrombospondin type I repeat domain, hPWTSR. Mol. Biol. Rep. 29:287-292.
7. Clausse, N., D. Baines, R. Moore, S. Brookes, C. Dickson, and G. Peters. 1993. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model. Virology 194:157-165.
8. Clausse, N., R. Smith, C. M. Calberg-Bacq, G. Peters, and C. Dickson. 1993. Mouse mammary-tumor virus activates Fgf-3/Int-2 less frequently in tumors from virgin than from parous mice. Int. J. Cancer 55:157-163.
9. Gattelli, A., M. C. Cirio, A. Quaglino, C. Schere-Levy, N. Martinez, M. Binaghi, R. P. Meiss, L. H. Castilla, and E. C. Kordon. 2004. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation. Cancer Res. 64:5193-5199.
10. Golovkina, T. V., I. Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Velaqq, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.
11. Kim, K. A., M. Kakitani, J. Zhao, T. Oshima, T. Tang, M. Binnerts, Y. Liu, B. Boyle, E. Park, P. Emtage, W. D. Funk, and K. Tomizuka. 2005. Mitogenic influence of human R-spondinl on the intestinal epithelium. Science 309: 1256-1259.
12. Kim, K. A., J. Zhao, S. Andarmani, M. Kakitani, T. Oshima, M. E. Binnerts, A. Abo, K. Tomizuka, and W. D. Funk. 2006. R-Spondin proteins: a novel link to beta-catenin activation. Cell Cycle 5:23-26.
13. Kordon, E. C., and G. H. Smith. 1998. An entire functional mammary gland may comprise the progeny from a single cell. Development 125:1921-1930.
14. Lowther, W., K. Wiley, G. H. Smith, and R. Callahan. 2005. A new common integration site, Int7, for the mouse mammary tumor virus in mouse mam-mary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J. Virol. 79:10093-10096.
15. Perlino, E., M. Lovecchio, R. A. Vacca, M. Fornaro, L. More, P. Ditonno, M. Battaglia, F. P. Selvaggi, M. G. Mastropasqua, P. Bufo, and L. R. Languino. 2000. Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma. Am. J. Pathol. 157:1727-1734.
16. Peters, G., A. E. Lee, and C. Dickson. 1984. Activation of cellular gene by mouse mammary tumour virus may occur early in mammary tumour development. Nature 309:273-275.
17. Schere-Levy, C., V. Buggiano, A. Quaglino, A. Gattelli, M. C. Cirio, I. Piazzon, S. Vanzulli, and E. C. Kordon. 2003. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp. Cell Res. 282:35-47.
18. Shattil, S. J., T. O'Toole, M. Eigenthaler, V. Thon, M. Williams, B. M. Babior, and M. H. Ginsberg. 1995. Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J. Cell Biol. 131:807-816.
19. Suzuki, T., S. Inoue, W. Kawabata, J. Akahira, T. Moriya, F. Tsuchiya, S. Ogawa, M. Muramatsu, and H. Sasano. 2001. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br. J. Cancer 85:1731-1737.
20. Szeto, W., W. Jiang, D. A. Tice, B. Rubinfeld, P. G. Hollingshead, S. E. Fong, D. L. Dugger, T. Pham, D. G. Yansura, T. A. Wong, J. C. Grimaldi, R. T. Corpuz, J. S. Singh, G. D. Frantz, B. Devaux, C. W. Crowley, R. H. Schwall, D. A. Eberhard, L. Rastelli, P. Polakis, and D. Pennica. 2001. Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res. 61:4197-4205.
21. Takahashi, S., T. Urano, F. Tsuchiya, T. Fujimura, T. Kitamura, Y. Ouchi, M. Muramatsu, and S. Inoue. 2003. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int. J. Cancer 106:310-315.
22. Walpole, S. M., K. T. Hiriyana, A. Nicolaou, E. L. Bingham, J. Durham, M. Vaudin, M. T. Ross, J. R. Yates, P. A. Sieving, and D. Trump. 1999. Identification and characterization of the human homologue (RAI2) of a mouse retinoic acid-induced gene in Xp22. Genomics 55:275-283.
23. Widschwendter, M., A. Widschwendter, T. Welte, G. Daxenbichler, A. G. Zeimet, A. Bergant, J. Berger, J. P. Peyrat, S. Michel, W. Doppler, and C. Marth. 1999. Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro. Br. J. Cancer 79:204-210.
24. Zhu, W. Y., C. S. Jones, S. Amin, K. Matsukuma, M. Haque, V. Vuligonda, R. A. Chandraratna, and L. M. De Luca. 1999. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res. 59:85-90.
25. Zutter, M. M., S. A. Santoro, W. D. Staatz, and Y. L. Tsung. 1995. Reexpression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 92:7411-7415.